Меню
Набор по приглашению NCT07395505

Postoperative Results and Outcomes in Surgical Pelvic Exenteration

Наблюдательное Rectal Cancer Recurrent Pelvic Exenteration Advanced Rectal Cancer

Ориентир для пациента и семьи

Простыми словами

Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.

Что изучают
Это наблюдательное исследование: исследуемое лечение участникам по протоколу не назначают.
Кому может быть актуально
Состояния в реестре: Rectal Cancer Recurrent, Pelvic Exenteration, Advanced Rectal Cancer. Базовые параметры: от 20 лет · Все.
Что важно проверить
Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
Где проводится
Тайвань
Следующий шаг
Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →
Официальное название

From Cure to Quality: Advancing Surgical and Postoperative Outcomes in Pelvic Exenteration

Обзор

The purpose of this study is to evaluate the feasibility of a standardized surgical and care process for patients with locally advanced or recurrent rectal cancer that has spread to nearby pelvic organs. When cancer invades adjacent structures (such as the sacrum, bladder, or prostate), a complex procedure called pelvic exenteration (PE) is often required to remove the tumor entirely. This research does not involve testing new or experimental surgical techniques. All procedures performed in this study are part of standard clinical practice. Instead, the focus of this project is to: Standardize Procedures: Create consistent, high-quality steps for the surgical team to follow. Improve Teamwork: Enhance coordination between different medical specialists (such as colorectal surgeons, urologists, and oncologists) to provide better care. Track Outcomes: Use a patient registry to monitor clinical data and quality of life after surgery through patient-reported surveys. A total of 24 adult patients will be enrolled over a three-year period. By refining these workflows and monitoring patient recovery, the study aims to ensure that these complex surgeries are performed as safely and effectively as possible.

Подробное описание

This prospective, single-center surgical feasibility study is designed to establish and validate standardized protocols for patients undergoing pelvic exenteration (PE), with or without sacrectomy, for locally advanced or recurrent rectal cancer invading adjacent pelvic structures.

The study focuses on three primary operational pillars:

1. Standardization of Surgical Techniques and SOPs The project aims to refine and standardize complex surgical maneuvers to ensure technical consistency across cases. This includes:

Precise identification and preservation of pelvic nerves.

Intraoperative assessment of sacrectomy levels (specifically targeting S2-S4).

Standardization of urological procedures and advanced reconstructive approaches for the pelvic floor.

Implementation and practical validation of Standard Operating Procedures (SOPs) to achieve consistent R0 resection margins. 2. Prospective Data Integration and Quality of Life Monitoring A systematic case registry will be established to capture comprehensive perioperative clinical data. Beyond clinical metrics, the study integrates Patient-Reported Outcome Measures (PROMs) to evaluate the impact of PE on long-term postoperative function and quality of life. This data will be used to optimize clinical workflows and improve patient counseling regarding functional recovery. 3. Multidisciplinary Team (MDT) Synergy The study reinforces a collaborative care model involving colorectal surgery, urology, orthopedics, oncology, radiology, and pathology. By strengthening MDT collaboration, the project aims to enhance perioperative care quality, from preoperative surgical candidacy review to postoperative management.

As a feasibility study, the enrollment of 24 patients over three years will serve as a pilot to confirm the practicality of these SOPs and the efficiency of the MDT workflow in a high-complexity surgical setting. All procedures fall within the scope of standard clinical practice; the research focus remains on the optimization of care delivery and process standardization.

Первичные конечные точки

  • Short-term outcome [Срок оценки: 2026 to 2031]
  • Short-term outcome [Срок оценки: 2026 to 2031]
Вторичные конечные точки (3)
  • Short-term outcome [Срок оценки: 2026 to 2031]
  • Short-term outcome [Срок оценки: 2026 to 2031]
  • Short-term outcome [Срок оценки: 2026 to 2031]

Критерии участия

Критерии включения

  • Adult patients aged ≥20 years.
  • Histologically confirmed rectal adenocarcinoma or anal adenocarcinoma.
  • Tumor invasion of sacrum (requiring sacrectomy, S2-S4) or anterior structures (e.g., prostate), or lateral structures(SLAM, vessels, nerve) where resection of the invaded organ is necessary to achieve R0 resection, as determined by MDT.
  • Surgical candidacy confirmed by multidisciplinary review (colorectal surgery, urology, orthopedics, oncology, radiology, pathology).
  • Preoperative imaging (MRI, PET/CT) confirming resectable disease without distant metastasis.
  • Signed informed consent obtained.

Критерии исключения

  • Unresectable disease or widespread distant metastasis.
  • Severe comorbidities rendering major surgery or anesthesia unsafe.
  • Patients unable to complete postoperative follow-up or unwilling to participate in PROMs assessment.

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Нет

Дизайн исследования

Модель наблюдения
Когортное

Центры проведения

Тайвань · 1 центр
  • Chang Gung Memorial Hospital, Linkou — Taoyuan

Публикации

  • Hsu YJ, Yu ZH, Jong BK, You JF, Yu YL, Liao CK, Lai CC, Chern YJ. Short- and long-term outcomes of minimally invasive vs. open pelvic exenteration in rectal tumours: a focused meta-analysis. Int J Colorectal Dis. 2025 Apr 3;40(1):86. doi: 10.1007/s00384-025-04876-z. PMID 40180681

Идентификаторы

NCT: NCT07395505 · 202501190A3C5001

Первоисточники (государственные реестры)

Открыть это исследование на ClinicalTrials.gov ↗